Cornerstone Capital Management Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$5.08M	Buy	347,700 +171,500	+97%	+$2.41M	0.04%	445
2017 Q3	$2.23M	Buy	176,200 +108,500	+160%	+$1.38M	0.02%	703
2017 Q2	$803K	Sell	67,700 -394,449	-85%	-$4.91M	0.01%	954
2017 Q1	$6.83M	Buy	462,149 +147,149	+47%	+$2.38M	0.05%	387
2016 Q4	$5.1M	Sell	315,000 -800	-0.3%	-$14.5K	0.04%	464
2016 Q3	$5.72M	Buy	+315,800	New	+$6.17M	0.04%	435

Other funds holding HZNP

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cornerstone Capital Management Holdings's HZNP Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 97% in Q4 2017, buying an estimated $2.41M and bringing the position to 347,700 shares worth $5.08M. The position accounts for 0.04% of the portfolio, ranked #445.

Cornerstone Capital Management Holdings first reported a position in HZNP in Q3 2016 and has held it in 6 quarters since. The position peaked at $6.83M in Q1 2017. 183 funds tracked by Wall St. Rank hold HZNP as of Q4 2017.

Cornerstone Capital Management Holdings held 347,700 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $5.08M as of Q4 2017.
Cornerstone Capital Management Holdings bought 171,500 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2017, an estimated $2.41M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.04% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #445 holding.
Cornerstone Capital Management Holdings first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2016 and has held it in 6 quarters since.
Cornerstone Capital Management Holdings's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.83M in Q1 2017.
183 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.